-
Ontology-guided clustering enables proteomic analysis of rare pediatric disorders. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-27
Ericka C M Itang,Vincent Albrecht,Alicia-Sophie Schebesta,Marvin Thielert,Anna-Lisa Lanz,Katharina Danhauser,Jessica Jin,Tobias Prell,Sophie Strobel,Christoph Klein,Matthias Mann,Susanne Pangratz-Fuehrer,Johannes Mueller-ReifThe study of rare pediatric disorders is fundamentally limited by small patient numbers, making it challenging to draw meaningful biological conclusions. To address this, we developed a framework integrating clinical ontologies with proteomic profiling, enabling the systematic analysis of rare conditions in aggregate. We applied this approach to urine and plasma samples from 1140 children and adolescents
-
FOXK2 in skeletal muscle development: a new pathogenic gene for congenital myopathy with ptosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-23
Peixuan Wu,Nan Song,Yang Xiang,Zhe Tao,Bing Mao,Ruochen Guo,Xin Wang,Dan Wu,Zhenzhen Zhang,Xin Chen,Duan Ma,Tianyu Zhang,Bingtao Hao,Jing MaCongenital ptosis, a genetic disorder involving levator palpebrae muscle dysfunction, is often associated with congenital myopathy. The genetic causes of this condition remain poorly understood. In this study, we identified FOXK2 mutations in five pedigrees with congenital myopathy and ptosis through whole exome sequencing and Sanger sequencing. Zebrafish with foxk2 deficiency exhibited underdeveloped
-
LXR pathway drives hormonal response intensity in polycystic ovary syndrome. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-21
Sarah Dallel,Manon Despalles,Margaux Tore,Yoan Renaud,Ayhan Kocer,Christelle Damon-Soubeyrand,Pierre Pouchin,Caroline Vachias,Katia Boutourlinsky,Céline Gonthier-Gueret,Angélique De Haze,Phelipe Sanchez,Jean-Christophe Pointud,Erwan Bouchareb,Marine Vialat,Aurélie Lagarde,Cristina Gulunga,Laure Chaput,Aurélie Vega,Florence Brugnon,Igor Tauveron,Amalia Trousson,Cyrille de Joussineau,Françoise DegoulGonadotropin injections used to stimulate oocyte production during assisted reproductive technology (ART) procedures are associated with the risk of an abnormal response in predisposed patients suffering polycystic ovary syndrome (PCOS). Liver X receptors (LXR) pathway has been identified as key regulators during this process. This study explores the integration of the hormonal signals, cellular networks
-
Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-21
Nieves Fernández-Gallego,Blanca Anega,Susana Luengo-Arias,Maider Bizkarguenaga,Rubén Gil-Redondo,Nieves Embade,Laura Navarrete-Arias,Marta Ramírez-Huesca,Emigdio Álvarez-Corrales,Sara G Dosil,Raquel Castillo-González,Amelia Rojas-Gomez,Inés Espeleta,Sara Martínez-Martínez,Arantzazu Alfranca,Virginia G de Yebenes,Noa Beatriz Martín-Cófreces,Julián Aragonés,Pilar Martin,Oscar Millet,Francisco Sánchez-MadridThe L-Leu amino acid transporter SLC7A5 has become an important target in inflammation and cancer. However, its role in acute graft-versus-host disease (aGVHD) and graft versus tumor (GVT) remains unexplored. We demonstrate that SLC7A5 deletion affected T cell activation, expansion and survival, and reduced IFNγ and granzyme B expression, thus controlling aGVHD, but without effect on tumor growth.
-
Uncovering biomarkers for chronic toxoplasmosis detection highlights alternative pathways shaping parasite dormancy. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-19
Marie G Robert,Christopher Swale,Belen Pachano,Léa Dépéry,Valeria Bellini,Céline Dard,Dominique Cannella,Charlotte Corrao,Lucid Belmudes,Yohann Couté,Alexandre Bougdour,Hervé Pelloux,Emmanuelle Chapey,Martine Wallon,Marie-Pierre Brenier-Pinchart,Mohamed-Ali HakimiToxoplasma gondii, a neurotropic protozoan, causes toxoplasmosis, a prevalent zoonotic and food-borne infection, posing significant risks to immunocompromised individuals and congenital cases. The chronic phase, characterized by dormant, cyst-forming bradyzoites, is central to disease progression but is poorly understood due to the lack of serological tests to detect bradyzoite-specific antigens. This
-
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-19
Gabriel Morin,Alexandre P Garneau,Nabiha Bouzakher,Louise Ségot,Antoine Fraissenon,Amélie Blondel,Florence Petit,Caroline Chopinet,Franck Mayeux,Pierre Fayoux,Anne Dompmartin,Christine Bodemer,Estelle Balducci,Sophie Kaltenbach,Patrick Villarese,Vahid Asnafi,Christophe Legendre,Christine Broissand,Sylvie Fraitag,Chloé Quelin,Nicolas Goudin,Laurent Guibaud,Guillaume CanaudMutations in PIK3R1 have recently been identified in patients with overgrowth syndromes and complex vascular malformations. PIK3R1 encodes p85α which acts as the regulatory subunit of the lipid kinase PI3Kα. PIK3R1 mutations result in the excessive activation of the AKT/mTOR pathway. Currently, there are no approved treatments specifically dedicated to patients with PIK3R1 mutations, and medical care
-
High-purity AAV vector production utilizing recombination-dependent minicircle formation and genetic coupling. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-16
Hao Liu,Nan Liu,Chen Zhou,Ailing Du,Mayank Kapadia,Phillip W L Tai,Erik Barton,Guangping Gao,Dan WangTriple transfection of HEK293 cells is the most widely used method for producing recombinant adeno-associated virus (rAAV), a leading gene delivery vector for human gene therapy. Despite its tremendous success, this approach generates several vector-related impurities that could potentially compromise the safety and potency of rAAV. In this study, we introduce a method for high-purity AAV vector production
-
EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-06
Dana Krauß,Veronica Moreno-Viedma,Emi Adachi-Fernandez,Cristiano de Sá Fernandes,Jakob-Wendelin Genger,Ourania Fari,Bernadette Blauensteiner,Dominik Kirchhofer,Nikolina Bradaric,Valeriya Gushchina,Georgios Fotakis,Thomas Mohr,Ifat Abramovich,Inbal Mor,Martin Holcmann,Andreas Bergthaler,Arvand Haschemi,Zlatko Trajanoski,Juliane Winkler,Eyal Gottlieb,Maria SibiliaInhibition of the epidermal growth factor receptor (EGFR) shows clinical benefit in metastatic colorectal cancer (CRC) patients, but KRAS-mutations are known to confer resistance. However, recent reports highlight EGFR as a crucial target to be co-inhibited with RAS inhibitors for effective treatment of KRAS mutant CRC. Here, we investigated the tumor cell-intrinsic contribution of EGFR in KRASG12D
-
A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-28
Sara Lucchini,James G Nicholson,Xinyu Zhang,Jacob Househam,Yau Mun Lim,Maximilian Mossner,Thomas O Millner,Sebastian Brandner,Trevor Graham,Silvia MarinoGlioblastoma remains incurable and recurs in all patients. Here we design and characterize a novel induced-recurrence model in which mice xenografted with primary patient-derived glioma initiating/stem cells (GIC) are treated with a therapeutic regimen closely recapitulating patient standard of care, followed by monitoring until tumours recur (induced recurrence patient-derived xenografts, IR-PDX)
-
Predictive modeling of glioblastoma recurrence for therapeutic target identification. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-28
Hrvoje Miletic,Thomas Daubon -
Spatial gene regulatory networks driving cell state transitions during human liver disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-25
Nigel L Hammond,Syed Murtuza Baker,Sokratia Georgaka,Ali Al-Anbaki,Elliot Jokl,Kara Simpson,Rosa Sanchez-Alvarez,Varinder S Athwal,Huw Purssell,Ajith K Siriwardena,Harry V M Spiers,Mike J Dixon,Leoma D Bere,Adam P Jones,Michael J Haley,Kevin N Couper,Nicoletta Bobola,Andrew D Sharrocks,Neil A Hanley,Magnus Rattray,Karen Piper HanleyLiver fibrosis is a major cause of death worldwide. As a progressive step in chronic liver disease, fibrosis is almost always diagnosed too late with limited treatment options. Here, we uncover the spatial transcriptional landscape driving human liver fibrosis using single nuclei RNA and Assay for Transposase-Accessible Chromatin (ATAC) sequencing to deconvolute multi-cell spatial transcriptomic profiling
-
Metabolic reprogramming in polycystic kidney disease and other renal ciliopathies. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-22
Sara Clerici,Alessandra BolettaPrimary cilia are solitary organelles formed by a microtubule-based skeleton protruding in a single copy on the surface of most cells. Alterations in their function cause a plethora of human conditions collectively called the ciliopathies. The kidney is frequently and severely affected in the ciliopathies, presenting with a spectrum of phenotypes. Cyst formation is a common trait of all renal ciliopathies
-
SOX9-dependent fibrosis drives renal function in nephronophthisis. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-10
Maulin Mukeshchandra Patel,Vasileios Gerakopoulos,Bryan Lettenmaier,Eleni Petsouki,Kurt A Zimmerman,John A Sayer,Leonidas TsiokasFibrosis is a key feature of a broad spectrum of cystic kidney diseases, especially autosomal recessive kidney disorders such as nephronophthisis (NPHP). However, its contribution to kidney function decline and the underlying molecular mechanism(s) remains unclear. Here, we show that kidney-specific deletion of Fbxw7, the recognition receptor of the SCFFBW7 E3 ubiquitin ligase, results in a juvenile-adult
-
Clinically translatable mitochondrial gene therapy in muscle using tandem mtZFN architecture. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-09
Pavel A Nash,Keira M Turner,Christopher A Powell,Lindsey Van Haute,Pedro Silva-Pinheiro,Felix Bubeck,Ellen Wiedtke,Eloïse Marques,Dylan G Ryan,Dirk Grimm,Payam A Gammage,Michal MinczukMutations in the mitochondrial genome (mtDNA) often lead to clinical pathologies. Mitochondrially-targeted zinc finger nucleases (mtZFNs) have been successful in reducing the levels of mutation-bearing mtDNA both in vivo and in vitro, resulting in a shift in the genetic makeup of affected mitochondria and subsequently to phenotypic rescue. Given the uneven distribution in the mtDNA mutation load across
-
A decisive technical leap forward for personalized medicine to treat mitochondrial diseases. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-09
Abi S Ghifari,Martin Ott -
Generalization of neoantigen-based tumor vaccine by delivering peptide-MHC complex via oncolytic virus. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-07
Chenyi Wang,Yingjun Shi,Da Zhang,Yupeng Sun,Junjie Xie,Bingchen Wu,Cuilin Zhang,Xiaolong LiuNeoantigen vaccine is a promising breakthrough in tumor immunotherapy. However, the application of this highly personalized strategy in the treatment of solid tumors is hindered by several obstacles, including very costly and time-consuming preparation steps, uncertainty in prediction algorithms and tumor heterogeneity. Universalization of neoantigen vaccine is an ideal yet currently unattainable solution
-
Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-05-01
Yi-Cheng Chang,Meng-Lun Hsieh,Hsiao-Lin Lee,Siow-Wey Hee,Chi-Fon Chang,Hsin-Yung Yen,Yi-An Chen,Yet-Ran Chen,Ya-Wen Chou,Fu-An Li,Yi-Yu Ke,Shih-Yi Chen,Ming-Shiu Hung,Alfur Fu-Hsin Hung,Jing-Yong Huang,Chu-Hsuan Chiu,Shih-Yao Lin,Sheue-Fang Shih,Chih-Neng Hsu,Juey-Jen Hwang,Teng-Kuang Yeh,Ting-Jen Rachel Cheng,Karen Chia-Wen Liao,Daniel Laio,Shu-Wha Lin,Tzu-Yu Chen,Chun-Mei Hu,Ulla Vogel,Daniel Saar -
Getting to the heart of cardiovascular complications associated with inflammatory arthritis. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-03
Hong Shi,Brian H Annex -
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-01
Georgina D Barnabas,Tariq A Bhat,Verena Goebeler,Pascal Leclair,Nadine Azzam,Nicole Melong,Colleen Anderson,Alexis Gom,Seohee An,Enes K Ergin,Yaoqing Shen,Agustina Conrrero,Andrew J Mungall,Karen L Mungall,Christopher A Maxwell,Gregor S D Reid,Martin Hirst,Steven Jones,Jennifer A Chan,Donna L Senger,Jason N Berman,Seth J Parker,Jonathan W Bush,Caron Strahlendorf,Rebecca J Deyell,C James Lim,PhilippGenomics has transformed the diagnostic landscape of pediatric malignancies by identifying and integrating actionable features that refine diagnosis, classification, and treatment. Yet, translating precision oncology data into effective therapies for hard-to-cure childhood, adolescent, and young adult malignancies remains a significant challenge. We present the case for combining proteomics with patient-derived
-
Saccharin disrupts bacterial cell envelope stability and interferes with DNA replication dynamics. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-01
Rubén de Dios,Kavita Gadar,Chris R Proctor,Evgenia Maslova,Jie Han,Mohamed A N Soliman,Dominika Krawiel,Emma L Dunbar,Bhupender Singh,Stelinda Peros,Tom Killelea,Anna-Luisa Warnke,Marius M Haugland,Edward L Bolt,Christian S Lentz,Christian J Rudolph,Ronan R McCarthySaccharin has been part of the human diet for over 100 years, and there is a comprehensive body of evidence demonstrating that it can influence the gut microbiome, ultimately impacting human health. However, the precise mechanisms through which saccharin can impact bacteria have remained elusive. In this work, we demonstrate that saccharin inhibits cell division, leading to cell filamentation with
-
Targeting HPK1 inhibits neutrophil responses to mitigate post-stroke lung and cerebral injuries. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-04-01
Tingting Zhang,Ying Sun,Jing Xia,Hongye Fan,Dingfang Shi,Qian Wu,Ming Huang,Xiao-Yu HouCirculating neutrophils are responsible for poor neurological outcomes and have been implicated in respiratory morbidity after acute ischemic stroke (AIS). However, the molecular mechanisms regulating neutrophil responses and their pathological relevance in post-stroke complications remain unclear. In this study, we investigated the involvement of hematopoietic progenitor kinase 1 (HPK1) in neutrophil
-
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-31
Hongze Chen,Muhammad Azhar Nisar,Joud Mulla,Xinjian Li,Kevin Cao,Shaolei Lu,Katsuya Nagaoka,Shang Wu,Peng-Sheng Ting,Tung-Sung Tseng,Hui-Yi Lin,Xiao-Ming Yin,Wenke Feng,Zhijin Wu,Zhixiang Cheng,William Mueller,Amalia Bay,Layla Schechner,Xuewei Bai,Chiung-Kuei HuangGlobal hepatic DNA methylation change has been linked to human patients with metabolic dysfunction-associated steatotic liver disease (MASLD). DNA demethylation is regulated by the TET family proteins, whose enzymatic activities require 2-oxoglutarate (2-OG) and iron that both are elevated in human MASLD patients. We aimed to investigate liver TET1 in MASLD progression. Depleting TET1 using two different
-
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-27
Ikuan Sam,Nadine Benhamouda,Lucie Biard,Laetitia Da Meda,Kristell Desseaux,Barouyr Baroudjan,Ines Nakouri,Marion Renaud,Aurélie Sadoux,Marina Alkatrib,Jean-François Deleuze,Maxime Battistella,Yimin Shen,Matthieu Resche-Rigon,Samia Mourah,Celeste Lebbe,Eric TartourMetastatic melanoma can be treated with anti-PD-1 monotherapy or in combination with anti-CTLA-4 or anti-Lag3. However, combination therapy is associated with a high risk of toxicity. Recently, we reported that high plasma soluble CD27 (sCD27) levels reflect the intratumoral interaction of CD70-CD27 and dysfunctional T cells in the tumor microenvironment of renal cell carcinoma. In this study, we first
-
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-27
Alexandra Helleux,Guillaume Davidson,Antonin Lallement,Fatima Al Hourani,Alexandre Haller,Isabelle Michel,Anas Fadloun,Christelle Thibault-Carpentier,Xiaoping Su,Véronique Lindner,Thibault Tricard,Hervé Lang,Nizar M Tannir,Irwin Davidson,Gabriel G MaloufThe oncogenic mechanisms by which TFE3 fusion proteins drive translocation renal cell carcinoma (tRCC) are poorly characterized. Here, we integrated loss and gain of function experiments with multi-omics analyses in tRCC cell lines and patient tumors. High nuclear accumulation of NONO-TFE3 or PRCC-TFE3 fusion proteins promotes their broad binding across the genome at H3K27ac-marked active chromatin
-
Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-26
Bo He,Kira H Wood,Zhi-Jie Li,Judith A Ermer,Ji Li,Edward R Bastow,Suraj Sakaram,Phillip K Darcy,Lisa J Spalding,Cameron T Redfern,Jordi Canes,Mafalda Oliveira,Aleix Prat,Javier Cortes,Erik W Thompson,Bruce A Littlefield,Andrew Redfern,Ruth GanssThe intratumoral immune milieu is crucial for the success of anti-cancer immunotherapy. We show here that stromal modulation by the tubulin-binding anti-cancer drugs combretastatin A4 (CA-4) and eribulin improved tumor perfusion and anti-tumor immunity. This was achieved by reverting highly proliferative, angiogenic pericytes into a quiescent, contractile state which durably normalized the vascular
-
Beyond mitotic arrest: the diverse effects of microtubule-targeting drugs on tumor vasculature. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-26
April L Risinger -
Modulating CCTG repeat expansion toxicity in DM2 Drosophila model through TDP1 inhibition. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-25
Yingbao Zhu,Shengwei Xiao,Xinxin Guan,Haitao Deng,Liqiang Ai,Kaijing Fan,Jin Xue,Guangxu Li,Xiaoxue Bi,Qiao Xiao,Yuanjiang Huang,Lin Jiang,Wen Huang,Peng Jin,Ranhui DuanMyotonic dystrophy type 2 (DM2), caused by CCTG repeat expansion, is a common adult-onset disorder characterized by myotonia and progressive muscle degeneration with no effective treatment. Here, we identified Tyrosyl-DNA phosphodiesterase 1 (TDP1) as a novel modifier for DM2 therapeutic intervention through a high-throughput chemical screening of 2160 compounds. Moreover, we detailed how both genetic
-
PARP7 as a new target for activating anti-tumor immunity in cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-24
Katerina Popova,Johannes Benedum,Magdalena Engl,Carola Lütgendorf-Caucig,Piero Fossati,Joachim Widder,Klaus Podar,Dea SladeADP-ribosyl transferases (ARTs) are a family of enzymes which catalyze the addition of a chain (PARylation) or a single moiety (MARylation) of ADP-ribose to their substrates. PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative regulator of the type I interferon (IFN-I) and nuclear receptor signaling, and due to its aberrant expression
-
DNA methylation changes during acute COVID-19 are associated with long-term transcriptional dysregulation in patients' airway epithelial cells. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-21
Marey Messingschlager,Sebastian D Mackowiak,Maria Theresa Voelker,Matthias Bieg,Jennifer Loske,Robert Lorenz Chua,Johannes Liebig,Sören Lukassen,Loreen Thürmann,Anke Seegebarth,Sven Twardziok,Daria Doncevic,Carl Herrmann,Stephan Lorenz,Sven Klages,Fridolin Steinbeis,Martin Witzenrath,Florian Kurth,Christian Conrad,Leif E Sander,Naveed Ishaque,Roland Eils,Irina Lehmann,Sven Laudi,Saskia TrumpMolecular changes underlying the persistent health effects after SARS-CoV-2 infection remain poorly understood. To discern the gene regulatory landscape in the upper respiratory tract of COVID-19 patients, we performed enzymatic DNA methylome and single-cell RNA sequencing in nasal cells of COVID-19 patients (n = 19, scRNA-seq n = 14) and controls (n = 14, scRNA-seq n = 10). In addition, we resampled
-
Microbiome-derived secondary bile acids promote repair of colonic mucosa after injury. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-21
Brecht Attema,Folkert Kuipers -
Targeting FKBP51 prevents stress-induced preterm birth. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-17
Ozlem Guzeloglu-Kayisli,Asli Ozmen,Busra Cetinkaya Un,Burak Un,Jacqueline Blas,Isabella Johnson,Andrea Thurman,Mark Walters,David Friend,Umit A Kayisli,Charles J LockwoodPreterm birth (PTB) is a leading cause of perinatal morbidity and mortality, with maternal stress-related disorders, such as depression and anxiety, linked to idiopathic PTB (iPTB). At the maternal-fetal interface, decidualized stromal cells (DSCs) exclusively express the progesterone receptor (PR) and play pivotal roles in maintaining pregnancy and initiating labor. DSCs also express FKBP51, a protein
-
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-14
Ravindra Pramod Deshpande,Kerui Wu,Shih-Ying Wu,Abhishek Tyagi,Eleanor C Smith,Jee-Won Kim,Kounosuke WatabeWe aimed to restore MHC-I expression on the surface of solid tumors including breast cancer and melanoma cells to regain sensitivity to immunotherapy and suppress metastatic progression. We screened a natural compound library and identified macbecin II as a reagent that upregulates MHC-I expression and induces antigen-dependent cell death in pre-invasive and invasive breast cancer models. Furthermore
-
Immune training enhances anti-viral responses and improves outcomes in Pax5-/+ mice susceptible to chronic infection. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-13
Zhe Lu,Olivia Stencel,Wei Liu,Eleni Vasileiou,Haifeng C Xu,Piyush Pandey,Paweł Stachura,Abdelrahman Elwy,Anastassia Tsombal,Ann-Sophie Mai,Franziska Auer,Mina N F Morcos,Maximilian Seidl,Sarah Koziel,Peter-Martin Bruch,Sascha Dietrich,Sarah Elitzur,Gunther Hartmann,Karl S Lang,Stefan Janssen,Ute Fischer,Sanil Bhatia,Philipp A Lang,Arndt Borkhardt,Julia Hauer,Aleksandra A PandyraViral infections pose a significant global burden. Host susceptibility to pathogens is determined by many factors including genetic variation that can lead to immunodeficient or dysregulated antiviral immune responses. Pax5 heterozygosity (Pax5-/+), resulting in reduced PAX5 levels in mice, mimics germline or somatic PAX5 dysregulation contributing to diseases such as childhood B-cell precursor acute
-
Bile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-10
Antoine Jalil,Alessia Perino,Yuan Dong,Jéromine Imbach,Colin Volet,Eduard Vico-Oton,Hadrien Demagny,Lucie Plantade,Hector Gallart-Ayala,Julijana Ivanisevic,Rizlan Bernier-Latmani,Siegfried Hapfelmeier,Kristina SchoonjansHost-microbiome communication is frequently perturbed in gut pathologies due to microbiome dysbiosis, leading to altered production of bacterial metabolites. Among these, 7α-dehydroxylated bile acids are notably diminished in inflammatory bowel disease patients. Herein, we investigated whether restoration of 7α-dehydroxylated bile acids levels by Clostridium scindens, a human-derived 7α-dehydroxylating
-
Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-07
Xun Zhou,Eva Berenger,Yong Shi,Vera Shirokova,Elena Kochetkova,Tina Becirovic,Boxi Zhang,Vitaliy O Kaminskyy,Yashar Esmaeilian,Kayoko Hosaka,Cecilia Lindskog,Per Hydbring,Simon Ekman,Yihai Cao,Maria Genander,Marcin Iwanicki,Erik Norberg,Helin Vakifahmetoglu-NorbergTumors often recapitulate programs to acquire invasive and dissemination abilities, during which pro-metastatic proteins are distinctively stabilized in cancer cells to drive further progression. Whether failed protein degradation affects the metastatic programs of cancer remains unknown. Here, we show that the human cancer cell-specific knockout (KO) of LAMP-2A, a limiting protein for chaperone-mediated
-
Precise mycobacterial species and subspecies identification using the PEP-TORCH peptidome algorithm. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-03-04
Duran Bao,Sudipa Maity,Lingpeng Zhan,Seungyeon Seo,Qingbo Shu,Christopher J Lyon,Bo Ning,Adrian Zelazny,Tony Y Hu,Jia FanMycobacterial infections pose a significant global health concern, requiring precise identification for effective treatment. However, diagnosing them is challenging due to inaccurate identifications and prolonged times. In this study, we aimed to develop a novel peptidome-based method using mycobacterial growth indicator tube (MGIT) cultures for faster and more accurate identification. We created the
-
Deubiquitination of RIPK3 by OTUB2 potentiates neuronal necroptosis after ischemic stroke. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-28
Fuqi Mei,Deyu Deng,Zijun Cao,Liyan Lou,Kangmin Chen,Minjie Hu,Zhenhu Zhu,Jiangyun Shen,Jianzhao Zhang,Jie Liang,Jingyong Huang,Min Bao,Ari Waisman,Xu WangAs a common and severe cerebrovascular disease, ischemic stroke casts a significant shadow over global health. Unfortunately, the mechanisms regulating neuronal death in the affected areas remain largely unclear. Here, we found that deletion of the deubiquitinating enzyme Otubain-2 (OTUB2) significantly alleviated ischemia-induced cerebral infarction and neurological deficits, accompanied by a reduction
-
Safe CAR-T: shedding light on CAR-related T-cell malignancies. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-28
Qibin Liao,Jianqing Xu -
Pertussis before, during and after Covid-19. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-24
Camille LochtAfter the Covid-19 pandemic, pertussis has made a spectacular comeback in Europe and many other parts of the world, while during the pandemic it had essentially disappeared because of the social distancing requirements. However, even before the Covid-19 pandemic, the disease was on the rise in many countries, especially those that have replaced whole-cell pertussis vaccines by acellular pertussis vaccines
-
X-linked myopathy with excessive autophagy: characterization and therapy testing in a zebrafish model. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-24
Lily Huang,Rebecca Simonian,Michael A Lopez,Muthukumar Karuppasamy,Veronica M Sanders,Katherine G English,Lacramioara Fabian,Matthew S Alexander,James J DowlingX-linked myopathy with excessive autophagy (XMEA), a rare childhood-onset autophagic vacuolar myopathy caused by mutations in VMA21, is characterized by proximal muscle weakness and progressive vacuolation. VMA21 encodes a protein chaperone of the vacuolar hydrogen ion ATPase, the loss of which leads to lysosomal neutralization and impaired function. At present, there is an incomplete understanding
-
Lanatoside C activates the E3 ligase STUB1 to inhibit FOXP3 transcriptional activity and promote antitumor immunity. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-20
Qian Zhou,Tong Yang,Xixi Yu,Bo Li,Jin Liu,Yongxin Mao,Rongxiang Guo,Zhuo Feng,Li Zhou,Guandi Zeng,Nan Li,Jinxia Liang,Lu Liu,Pengju Feng,Hong-Bing Shu,Liang ChenRegulatory T cells (Tregs) play critical roles in inhibiting antitumor immunity, which is dependent on FOXP3-mediated transcriptional activity. However, no Treg-specific therapeutics has been approved for clinical use. We performed a high-throughput screen of FDA-approved drugs for potential inhibitors of FOXP3 transcriptional activity. These efforts identified Lanatoside C (Lac), which potently inhibits
-
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-19
Nozomi Tomimatsu,Luis Fernando Macedo Di Cristofaro,Suman Kanji,Lorena Samentar,Benjamin Russell Jordan,Ralf Kittler,Amyn A Habib,Jair Machado Espindola-Netto,Tamara Tchkonia,James L Kirkland,Terry C Burns,Jann N Sarkaria,Andrea Gilbert,John R Floyd,Robert Hromas,Weixing Zhao,Daohong Zhou,Patrick Sung,Bipasha Mukherjee,Sandeep BurmaGlioblastomas (GBM) are routinely treated with high doses of ionizing radiation (IR), yet these tumors recur quickly, and the recurrent tumors are highly therapy resistant. Here, we report that IR-induced senescence of tumor cells counterintuitively spurs GBM recurrence, driven by the senescence-associated secretory phenotype (SASP). We find that irradiated GBM cell lines and patient derived xenograft
-
Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-17
Béatrice Demoures,Fabienne Soulet,Jean Descarpentrie,Isabel Galeano-Otero,José Sanchez Collado,Maria Casado,Tarik Smani,Alvaro González,Isabel Alves,Fabrice Lalloué,Bernard Masri,Estelle Rascol,Jean-William Dupuy,Cyril Dourthe,Frédéric Saltel,Anne-Aurélie Raymond,Iker Badiola,Serge Evrard,Bruno Villoutreix,Simon Pernot,Géraldine Siegfried,Abdel-Majid KhatibThe adipokine apelin has been directly implicated in various physiological processes during embryogenesis and human cancers. Nevertheless, the importance of the conversion of its precursor proapelin to mature apelin in tumorigenesis remains unknown. In this study, we identify Furin as the cellular proprotein convertase responsible for proapelin cleavage. We explore the therapeutic potential of targeting
-
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-13
Léana Gorse,Loïc Plessis,Stephen Wearne,Margaux Paradis,Miriam Pinilla,Rae Chua,Seong Soo Lim,Elena Pelluz,Gee-Ann Toh,Raoul Mazars,Caio Bomfim,Fabienne Hervé,Korian Lhaute,Damien Réveillon,Bastien Suire,Léa Ravon-Katossky,Thomas Benoist,Léa Fromont,David Péricat,Kenneth Neil Mertens,Amélie Derrien,Aouregan Terre-Terrillon,Nicolas Chomérat,Gwenaël Bilien,Véronique Séchet,Liliane Carpentier,MamadouIn 2020-2021, a "mysterious illness" struck Senegalese fishermen, causing severe acute dermatitis in over one thousand individuals following exposure through drift-net fishing activity. Here, by performing deep analysis of the environmental samples we reveal the presence of the marine dinoflagellate Vulcanodinium rugosum and its associated cyclic imine toxins. Specifically, we show that the toxin PortimineA
-
Model systems to study tumor-microbiome interactions in early-onset colorectal cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-13
Katharina M Richter,Marius Wrage,Carolin Krekeler,Tiago De Oliveira,Lena-Christin Conradi,Kerstin Menck,Annalen BleckmannColorectal cancer (CRC) is a major health problem, with an alarming increase of early-onset CRC (EO-CRC) cases among individuals under 50 years of age. This trend shows the urgent need for understanding the underlying mechanisms leading to EO-CRC development and progression. There is significant evidence that the gut microbiome acts as a key player in CRC by triggering molecular changes in the colon
-
Microbial metabolites tune amygdala neuronal hyperexcitability and anxiety-linked behaviors. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-05
Weonjin Yu,Yixin Xiao,Anusha Jayaraman,Yi-Chun Yen,Hae Ung Lee,Sven Pettersson,H Shawn JeChanges in gut microbiota composition have been linked to anxiety behavior in rodents. However, the underlying neural circuitry linking microbiota and their metabolites to anxiety behavior remains unknown. Using male C57BL/6J germ-free (GF) mice, not exposed to live microbes, increased anxiety-related behavior was observed correlating with a significant increase in the immediate early c-Fos gene in
-
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-03
Sven Mattern,Vanessa Hollfoth,Eyyub Bag,Arslan Ali,Philip Riemenschneider,Mohamed A Jarboui,Karsten Boldt,Mihaly Sulyok,Anabel Dickemann,Julia Luibrand,Stefano Fusco,Mirita Franz-Wachtel,Kerstin Singer,Benjamin Goeppert,Oliver Schilling,Nisar Malek,Falko Fend,Boris Macek,Marius Ueffing,Stephan SingerEsophagitis is a frequent, but at the molecular level poorly characterized condition with diverse underlying etiologies and treatments. Correct diagnosis can be challenging due to partially overlapping histological features. By proteomic profiling of routine diagnostic FFPE biopsy specimens (n = 55) representing controls, Reflux- (GERD), Eosinophilic-(EoE), Crohn's-(CD), Herpes simplex (HSV) and Candida
-
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-02-03
Audrey Burban,Cloe Tessier,Mathieu Larroquette,Joris Guyon,Cloe Lubiato,Mathis Pinglaut,Maxime Toujas,Johanna Galvis,Benjamin Dartigues,Emmanuelle Georget,H Artee Luchman,Samuel Weiss,David Cappellen,Nathalie Nicot,Barbara Klink,Macha Nikolski,Lucie Brisson,Thomas Mathivet,Andreas Bikfalvi,Thomas Daubon,Ahmad SharanekGlioblastoma is one of the most treatment-resistant and lethal cancers, with a subset of self-renewing brain tumour stem cells (BTSCs), driving therapy resistance and relapse. Here, we report that mubritinib effectively impairs BTSC stemness and growth. Mechanistically, bioenergetic assays and rescue experiments showed that mubritinib targets complex I of the electron transport chain, thereby impairing
-
Exposomics: a review of methodologies, applications, and future directions in molecular medicine. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-27
Melissa Wan,Elisabeth M Simonin,Mary Margaret Johnson,Xinyue Zhang,Xiangping Lin,Peng Gao,Chirag J Patel,Aroub Yousuf,Michael P Snyder,Xiumei Hong,Xiaobin Wang,Vanitha Sampath,Kari C NadeauThe exposome is the measure of all the exposures of an individual in a lifetime and how those exposures relate to health. Exposomics is the emerging field of research to measure and study the totality of the exposome. Exposomics can assist with molecular medicine by furthering our understanding of how the exposome influences cellular and molecular processes such as gene expression, epigenetic modifications
-
Boosting human immunology: harnessing the potential of immune organoids. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-27
Maximilian Moll,Dirk BaumjohannStudying the human immune system in vivo is challenging and often not possible. Therefore, most human immunology studies have been predominantly confined to peripheral blood analyses, which by themselves have inherent limitations, as many immune reactions take place within tissues. For example, potent antibody responses that contribute to fighting infections and provide protection following vaccination
-
Improving the odds of survival: transgenerational effects of infections. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-22
Victoria M Spanou,Theano P Andriopoulou,Evangelos J Giamarellos-Bourboulis,Mihai G NeteaRecent studies argue for a novel concept of the role of chromatin as a carrier of epigenetic memory through cellular and organismal generations, defining and coordinating gene activity states and physiological functions. Environmental insults, such as exposures to unhealthy diets, smoking, toxic compounds, and infections, can epigenetically reprogram germ-line cells and influence offspring phenotypes
-
Gut microbiota interact with breast cancer therapeutics to modulate efficacy. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-16
Alana A Arnone,Katherine Ansley,Arielle L Heeke,Marissa Howard-McNatt,Katherine L CookThe gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important factor in breast cancer etiology and treatment. Specifically, the impact of gut bacterial populations on breast cancer therapeutic outcomes is an emerging area of research. The microbiota's role in modifying the pharmacokinetics of chemotherapy and endocrine-targeting therapies
-
Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-10
Davina Biel,Marc Suárez-Calvet,Anna Dewenter,Anna Steward,Sebastian N Roemer,Amir Dehsarvi,Zeyu Zhu,Julia Pescoller,Lukas Frontzkowski,Annika Kreuzer,Christian Haass,Michael Schöll,Matthias Brendel,Nicolai FranzmeierIn Alzheimer's disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we assessed whether factors known to alter tau levels in AD modulate the association between fibrillar Aβ and secreted p-tau181 determined in the cerebrospinal fluid (CSF). To assess potentially
-
Oncolytic viruses expressing MATEs facilitate target-independent T-cell activation in tumors. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-09
Malin Peter,Bettina Mundt,Arne Menze,Norman Woller,Valery Volk,Amanda M Ernst,Leon A Öhler,Steven R Talbot,Heiner Wedemeyer,Christine Falk,Friedrich Feuerhake,Thomas C Wirth,Florian KühnelOncolytic viruses (OV) expressing bispecific T-cell engagers (BiTEs) are promising tools for tumor immunotherapy but the range of target tumors is limited. To facilitate effective T-cell stimulation with broad-range applicability, we established membrane-associated T-cell engagers (MATEs) harboring the protein transduction domain of the HIV-Tat protein to achieve non-selective binding to target cells
-
CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-06
Philipp Berg,Gabriele Ruppert-Seipp,Susanne Müller,Gabriele D Maurer,Jessica Hartmann,Udo Holtick,Christian J Buchholz,Markus B FunkSuspected adverse reactions following chimeric antigen receptor T-cell (CAR T) treatment include more and more cases of secondary T-cell malignancies. The causality assessment of such suspected reactions challenges established evaluation practices due to (i) patient and product-specific risk factors and (ii) incomplete data available with post-marketing reports submitted to competent authorities. This
-
Macrophage-induced enteric neurodegeneration leads to motility impairment during gut inflammation. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-06
Mona Breßer,Kevin D Siemens,Linda Schneider,Jonah E Lunnebach,Patrick Leven,Tim R Glowka,Kristin Oberländer,Elena De Domenico,Joachim L Schultze,Joachim Schmidt,Jörg C Kalff,Anja Schneider,Sven Wehner,Reiner SchneiderCurrent studies pictured the enteric nervous system and macrophages as modulators of neuroimmune processes in the inflamed gut. Expanding this view, we investigated the impact of enteric neuron-macrophage interactions on postoperative trauma and subsequent motility disturbances, i.e., postoperative ileus. In the early postsurgical phase, we detected strong neuronal activation, followed by transcriptional
-
A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-02
Yuncheng Bei,Ying Huang,Nandie Wu,Yishan Li,Ruihan Xu,Baorui Liu,Rutian LiThe adoptive transfer of TCR-T cells specific to neoantigens preferentially exhibits potent cytotoxicity to tumor cells and has shown promising efficacy in various preclinical human cancers. In this study, we first identified a functional TCR, Tcr-1, which selectively recognized the SYT-SSX fusion neoantigen shared by most synovial sarcomas. Engineered T-cell expressing Tcr-1 (Tcr-T1) demonstrated
-
PlexinD1 is a driver and a therapeutic target in advanced prostate cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2025-01-02
Jing Wei,Jing Wang,Wen Guan,Jingjing Li,Tianjie Pu,Eva Corey,Tzu-Ping Lin,Allen C Gao,Boyang Jason WuAggressive prostate cancer (PCa) variants associated with androgen receptor signaling inhibitor (ARSI) resistance and metastasis remain poorly understood. Here, we identify the axon guidance semaphorin receptor PlexinD1 as a crucial driver of cancer aggressiveness in metastatic castration-resistant prostate cancer (CRPC). High PlexinD1 expression in human PCa is correlated with adverse clinical outcomes
-
Beneficial microbiome and diet interplay in early-onset colorectal cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-09
Zhengyuan Zhou,Linda Kleis,Ana Depetris-Chauvin,Stefanie Jaskulski,Victoria Damerell,Karin B Michels,Biljana Gigic,Ute Nöthlings,Gianni PanagiotouColorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Although the risk of developing CRC increases with age, approximately 10% of newly diagnosed cases occur in individuals under the age of 50. Significant changes in dietary habits in young adults since industrialization create a favorable microenvironment for colorectal
-
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-09
Rosalie Matico,Karolien Grauwen,Dhruv Chauhan,Xiaodi Yu,Irini Abdiaj,Suraj Adhikary,Ine Adriaensen,Garcia Molina Aranzazu,Jesus Alcázar,Michela Bassi,Ellen Brisse,Santiago Cañellas,Shubhra Chaudhuri,Francisca Delgado,Alejandro Diéguez-Vázquez,Marc Du Jardin,Victoria Eastham,Michael Finley,Tom Jacobs,Ken Keustermans,Robert Kuhn,Josep Llaveria,Jos Leenaerts,Maria Lourdes Linares,Maria Luz Martín,RosaThe NLRP3 inflammasome plays a pivotal role in host defense and drives inflammation against microbial threats, crystals, and danger-associated molecular patterns (DAMPs). Dysregulation of NLRP3 activity is associated with various human diseases, making it an attractive therapeutic target. Patients with NLRP3 mutations suffer from Cryopyrin-Associated Periodic Syndrome (CAPS) emphasizing the clinical